Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
87.04 USD
-1.07%
Market Closed
Updated:
May 29, 2024
Edwards Lifesciences Corp
Cash & Cash Equivalents
|
Edwards Lifesciences Corp
Cash & Cash Equivalents Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash & Cash Equivalents
$1.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash & Cash Equivalents
$2.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
28%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash & Cash Equivalents
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
76%
|
CAGR 10-Years
28%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash & Cash Equivalents
$2.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash & Cash Equivalents
$6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash & Cash Equivalents
$2.8B
|
CAGR 3-Years
27%
|
CAGR 5-Years
27%
|
CAGR 10-Years
13%
|
See Also
What is Edwards Lifesciences Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.2B
USD
1.2B
USD
Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Cash & Cash Equivalents amounts to 1.2B USD.
What is Edwards Lifesciences Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
15%
15%
Over the last year, the Cash & Cash Equivalents growth was 40%. The average annual Cash & Cash Equivalents growth rates for Edwards Lifesciences Corp have been 1% over the past three years , 12% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
